secwatch.observer — SEC 8-K summary
======================================

Issuer:     IRADIMED CORP (IRMD)
CIK:        0001325618
Form:       8-K
Filed at:   2023-11-06T23:59:59+00:00
Accession:  0001558370-23-017757
Event type: regulatory
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Iradimed adopts clawback policy for executive compensation recovery effective Oct 2, 2023
--------------------------------------------------------------------------------

- Board adopted Incentive-Based Compensation Recovery Policy on Nov 2, 2023, effective Oct 2, 2023.
- Policy mandates recovery of erroneously awarded incentive-based compensation from current and former executive officers.
- Recovery triggered by an accounting restatement; no misconduct required for clawback.
- Policy complies with Nasdaq Rule 5608 and SEC Rule 10D-1; indemnification of executive officers prohibited.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1325618/000155837023017757/0001558370-23-017757-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1325618/000155837023017757/irmd-20231102x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-017757

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer